Literature DB >> 2608099

Characterization of the promastigote surface protease of Leishmania as a membrane-bound zinc endopeptidase.

J Bouvier1, C Bordier, H Vogel, R Reichelt, R Etges.   

Abstract

The effects of a variety of inhibitors suggested that the promastigote surface protease (PSP) of Leishmania might be a zinc metalloprotease. To investigate this possibility, we conducted atomic emission and absorption spectroscopic analyses, which show that PSP contains 1 atom of zinc per 63-kDa monomer. Further studies showed that the enzyme can be biosynthetically labeled with 65ZnCl2. The comparison of the amino acid sequence of Leishmania major PSP with nine other zinc metalloproteinases revealed significant similarity in the area of their zinc-binding sites. These data show clearly that the promastigote surface protease of Leishmania is a zinc metalloproteinase. Secondary structure analysis by circular dichroism spectroscopy indicates that PSP contains over 40% beta-strand and less than 20% alpha-helical structure. The molecular masses of amphiphilic PSP (152 kDa) and of hydrophilic PSP (142 kDa), determined by quantitative electron scattering, suggest that the purified enzyme occurs in solution, and presumably at the cell surface, as a non-covalent homodimer.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2608099     DOI: 10.1016/0166-6851(89)90155-2

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  14 in total

1.  Extrachromosomal genetic complementation of surface metalloproteinase (gp63)-deficient Leishmania increases their binding to macrophages.

Authors:  X Liu; K P Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

2.  Immunological analysis of the zinc-binding peptides of surface metalloproteinase (gp63) of Leishmania major.

Authors:  D Yang; M V Rogers; S J Brett; F Y Liew
Journal:  Immunology       Date:  1993-04       Impact factor: 7.397

3.  Surface Zn-proteinase as a molecule for defense of Leishmania mexicana amazonensis promastigotes against cytolysis inside macrophage phagolysosomes.

Authors:  M B Seay; P L Heard; G Chaudhuri
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

4.  gp63 homologues in Trypanosoma cruzi: surface antigens with metalloprotease activity and a possible role in host cell infection.

Authors:  Ileana C Cuevas; Juan J Cazzulo; Daniel O Sánchez
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

5.  Arginine aminopeptidase, an integral membrane protein of the Cryptosporidium parvum sporozoite.

Authors:  P C Okhuysen; H L DuPont; C R Sterling; C L Chappell
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

6.  Antigenicity and conformational analysis of the Zn(2+)-binding sites of two Zn(2+)-metalloproteases: Leishmania gp63 and mammalian endopeptidase-24.11.

Authors:  K P Soteriadou; A K Tzinia; E Panou-Pamonis; V Tsikaris; M Sakarellos-Daitsiotis; C Sakarellos; Y Papapoulou; R Matsas
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

7.  Identification and characterization of host-protective T-cell epitopes of a major surface glycoprotein (gp63) from Leishmania major.

Authors:  D M Yang; M V Rogers; F Y Liew
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

8.  GTPase Sar1 regulates the trafficking and secretion of the virulence factor gp63 in Leishmania.

Authors:  Smriti Parashar; Amitabha Mukhopadhyay
Journal:  J Biol Chem       Date:  2017-06-02       Impact factor: 5.157

Review 9.  Impact of Leishmania metalloprotease GP63 on macrophage signaling.

Authors:  Amandine Isnard; Marina T Shio; Martin Olivier
Journal:  Front Cell Infect Microbiol       Date:  2012-05-16       Impact factor: 5.293

10.  Molecular cloning and expression analysis of peptidase genes in the fish-pathogenic scuticociliate Miamiensis avidus.

Authors:  Jung Soo Seo; Eun Ji Jeon; Sung Hee Jung; Myoung Ae Park; Jin Woo Kim; Ki Hong Kim; Sung Ho Woo; Eun Hye Lee
Journal:  BMC Vet Res       Date:  2013-01-11       Impact factor: 2.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.